title: [Erectile dysfunction].
abstract: Erectile Dysfunction is one of the most prevalent sexual disorders in men. According to the current literature the prevalence is about 16% for all men. The diagnostic workup of a patient suffering from E.D. is a detailed anamnesis, a physical and endocrinological evaluation and the suggestion of the optimal therapeutic treatment. The therapeutic application of PDE-5 inhibitors has made the therapy of E.D. much easier. It is a safe and highly efficient therapeutic option. But man must not forget that in severe cases of erectile dysfunction, the application of SKAT therapy, penile implants or vacuum devices might be necessary. Since a functioning sex life is important not only for the men, but also for the couple, a more open attitude of us, physicians, is desirable to help more men who suffer from this sexual dysfunction.
authors.affiliation: Universitätsklinik für Urologie und Andrologie, Paracelsus Medizinische Privatuniversität Salzburg, Salzburg, Austria. b.esterbauer@salk.at
authors.forename: Brigitte
authors.initials: B
authors.lastname: Esterbauer
authors.forename: Andreas
authors.initials: A
authors.lastname: Jungwirth
mesh_terms: D000328:Adult; D000368:Aged; D000527:Alprostadil / Q000008:administration & dosage; D003430:Cross-Sectional Studies; D007172:Erectile Dysfunction / Q000453:epidemiology* / Q000209:etiology / Q000628:therapy; D006801:Humans; D015994:Incidence; D007275:Injections, Intravenous; D008297:Male; D008388:Marital Therapy; D008875:Middle Aged; D017060:Patient Satisfaction; D015917:Penile Prosthesis; D058986:Phosphodiesterase 5 Inhibitors; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors
chemical_list: D058986:Phosphodiesterase 5 Inhibitors; D010726:Phosphodiesterase Inhibitors; D000527:Alprostadil